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Abstract
Background: The instability faced by refugees may place them at increased risk of exposure to HIV infection.
Nakivale Refugee Settlement in southwestern Uganda hosts 68,000 refugees from 11 countries, many with high
HIV prevalence. We implemented an HIV screening program in Nakivale and examined factors associated with
new HIV diagnosis.
Methods: From March 2013-November 2014, we offered free HIV screening to all clients in the Nakivale Health
Center while they waited for their outpatient clinic visit. Clients included refugees and Ugandan nationals accessing
services in the settlement. Prior to receiving the HIV test result, participants were surveyed to obtain demographic
information including gender, marital status, travel time to reach clinic, refugee status, and history of prior HIV
testing. We compared variables for HIV-infected and non-infected clients using Pearson’s chi-square test, and used
multivariable binomial regression models to identify predictors of HIV infection.
Results: During the HIV screening intervention period, 330 (4%) of 7766 individuals tested were identified as
HIV-infected. Refugees were one quarter as likely as Ugandan nationals to be HIV-infected (aRR 0.27 [0.21, 0.34],
p < 0.0001). Additionally, being female (aRR 1.43 [1.14, 1.80], p = 0.002) and traveling more than 1 h to the clinic
(aRR 1.39 [1.11, 1.74], p = 0.003) increased the likelihood of being HIV-infected. Compared to individuals who were
married or in a stable relationship, being divorced/separated/widowed increased the risk of being HIV-infected
(aRR 2.41 [1.88, 3.08], p < 0.0001), while being single reduced the risk (aRR 0.60 [0.41, 0.86], p < 0.0001). Having been
previously tested for HIV (aRR 0.59 [0.47, 0.74], p < 0.0001) also lowered the likelihood of being HIV-infected.
Conclusions: In an HIV screening program in a refugee settlement in Uganda, Ugandan nationals are at higher risk
of having HIV than refugees. The high HIV prevalence among clients seeking outpatient care, including Ugandan
nationals and refugees, warrants enhanced HIV screening services in Nakivale and in the surrounding region.
Findings from this research may be relevant for other refugee settlements in Sub-Saharan Africa hosting
populations with similar demographics, including the 9 other refugee settlements in Uganda.
Keywords: HIV, Refugee, HIV testing, HIV screening, sub-Saharan Africa
* Correspondence: kolaughlin@partners.org
1Department of Emergency Medicine, Brigham and Women’s Hospital, 75
Francis Street, Boston, MA 02115, USA
2Medical Practice Evaluation Center, Department of Medicine, Massachusetts
General Hospital, 50 Staniford Street, 9th Floor, Boston, MA 02114-2698, USA
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
O’Laughlin et al. BMC Infectious Diseases  (2016) 16:695 
DOI 10.1186/s12879-016-2021-1
Background
Sub-Saharan Africa is home to approximately 3 million
refugees and asylum-seekers as well as 25.8 million
adults living with HIV/AIDS [1, 2]. Despite the large
number of refugees and the focused burden of HIV in
sub-Saharan Africa, the prevalence of HIV among refu-
gees is unknown. Furthermore, refugees face disrupted
community social structures and their ability to cope
with difficult living conditions is compromised [3, 4].
These factors may increase their vulnerability for expos-
ure to HIV and result in hardships when attempting to
access HIV-related services [4, 5]. Targeted interventions
to diagnose HIV-infected refugees and engage them in
medical care will likely improve survival and reduce
transmission of disease. These data will be essential to
initiate HIV treatment for all who need it as we aim to
end the global AIDS epidemic [6].
Working with local collaborators from Medical Teams
International (MTI) and the United Nations High Commis-
sioner for Refugees (UNHCR), we established a refugee-
centered research team focused on improving delivery
of HIV services for refugees and nationals in Nakivale
Refugee Settlement in southwestern Uganda. We con-
ducted a clinic-based HIV screening intervention study
at Nakivale Health Center [7]. Our primary objective
for this analysis was to evaluate the correlates of HIV in-
fection of those tested during this screening intervention.
Methods
Study design
This analysis is part of a larger study that compared a
Standard of Care period (January 15, 2013 to March 13,
2013) to an Intervention period (March 14, 2013 to
November 15, 2013) to assess the impact of an HIV
screening intervention at Nakivale Health Center [7].
The single intervention was that clients, including
refugees and Ugandan nationals, were offered free HIV
testing by dedicated research staff while waiting for their
outpatient department clinic visit. Approximately 21% of
all-comers to the outpatient department participated in
HIV screening [7]. Data was not collected on those who
did not participate in HIV screening. After signing writ-
ten consent forms, participants were orally administered
a structured questionnaire by research assistants. Data
was entered directly into a secure laptop computer.
Survey data included information such as gender, marital
status, travel time to reach clinic, refugee status, and
history of prior HIV testing. After the survey was
complete, participants were counseled regarding their
HIV test result and were given information about HIV
transmission with specific instructions on HIV preven-
tion and on how to follow-up with HIV clinic as applic-
able. For purposes of this research, we used data from
the ongoing intervention, which includes clients who
tested from March 14, 2013 through November 14,
2014, to evaluate demographic and socioeconomic
correlates of being diagnosed with a new HIV infection
during the screening intervention.
Study setting
This study was conducted in Nakivale Refugee Settle-
ment in southwestern Uganda. Nakivale was established
in 1960 to accommodate Rwandan refugees. It spans 71
square miles and hosts 68,000 refugees from 11 coun-
tries [8]. Most refugees are from four countries: the
Democratic Republic of the Congo (52%), Somalia
(16%), Burundi (15%) and Rwanda (15%) [8]. Nakivale
Health Center is the largest health clinic in the settle-
ment and is operated by the non-profit organization
Medical Teams International. Services at Nakivale
Health Center are accessed by refugees living in the
settlement, and importantly, also by Ugandan nationals
living in and around the settlement. There is an out-
patient department that is open on weekdays where cli-
nicians care for approximately 80 adult patients per day.
At Nakivale Health Center, HIV testing is free to all
clients and is performed using serial rapid HIV tests as
specified by the Uganda HIV Rapid Test Algorithm [9].
Antiretroviral therapy (ART) is provided free of charge
(during the time of this research ART was initiated at
CD4 ≤ 350/mm3 or WHO Stage III/IV based on 2010
WHO guidelines [10]). Pre-ART clients are monitored
with monthly clinic visits and are given co-trimoxazole
prophylaxis [11]. Three smaller clinics in the settlement
offer free HIV screening, pre-ART clinics, and ART
clinics. While HIV prevalence in Nakivale is unknown,
we found a prevalence of 4.5% during our initial HIV
screening intervention study conducted at Nakivale
Health Center [7]. The prevalence of HIV from the refu-
gees’ countries of origin ranges from 0.5 to 5.9% [12],
and the prevalence in the surrounding region of Uganda
is 7.3% [13].
Subject selection
Study participants were recruited by research assistants
through the use of HIV-related educational presenta-
tions conducted twice each morning to clients in the
outpatient department waiting area at Nakivale Health
Center. Eligibility criteria included: 1) 18 years or older;
2) ability to provide informed consent in one of four lan-
guages: Swahili, Kinyarwanda, Runyankore, or English;
3) not already known to be HIV-infected; and 4) no
prior participation in this research study. Clients were
invited to obtain a free rapid HIV test and were given
the test result while waiting for their outpatient depart-
ment clinic visit. Prior to the HIV screening interven-
tion, the standard of care was for clients to request a
free HIV test or to be referred for diagnostic HIV testing
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based on clinical suspicion. In these instances, the HIV
test was conducted in the outpatient department labora-
tory with results provided to clients later in the day or
the following morning.
Data collected/classification of endpoints
Four research assistants hired for the study performed
study recruitment, consent, surveying and rapid HIV
testing. These steps were offered in the four languages
listed above. Research assistants had experience in HIV
counseling and were trained in rapid HIV testing by
members of the Center for Disease Control and Preven-
tion (CDC) in Uganda. Participants were tested in a
semi-permanent two-room tent approximately 25 m
from the outpatient department. While the HIV test was
conducted, and prior to return of HIV test results,
research assistants performed the survey to collect de-
mographic and socioeconomic information. After the
survey was complete, prior to leaving the HIV testing area,
research assistants gave study participants their HIV test
result. Participants were counseled regarding their diagno-
sis and given appropriate instructions on how to enroll in
HIV clinical care when indicated.
Statistical methods
We report descriptive data as frequencies or medians
with interquartile range, as appropriate. For comparisons
between groups (HIV-infected and non-infected) for
univariate analyses of variables, we used Pearson’s chi-
square test. We then fit multivariable binomial regres-
sion models using a log link function to estimate
unadjusted and adjusted relative risk of testing as HIV-
infected. Variables were considered for inclusion in the
multivariate model if univariate screening p-value was
less than 0.10 and were ultimately included in the model
if the adjusted p-value was less than 0.05. Due to the
inherent association between the variables “refugee status”,
“live in Nakivale”, and “country of origin”, we considered
only “refugee status” for inclusion into our multivariable
model. Exact 95% confidence intervals (CI) for proportions
were calculated using the Pearson-Klopper method. Statis-
tical analyses were performed using SAS 9.4 (Cary, NC,
USA) and R version 3.1.2 (www.r-project.org).
Results
During the study period, we have records of 23,016
encounters at the clinic (which may include multiple
encounters of a single individual). Of these encounters,
65% were female, the median age was 32 (IQR: 25–43),
and 92% were refugees. Though study recruitment
occurred in the outpatient department clinic waiting
area, not all clients screened for HIV attended the
outpatient department clinic. Definitive HIV testing
results were obtained for 7766 subjects of which 52%
were female, median age was 28 years (IQR: 22–37), and
69% were refugees (Table 1). Of all clients tested, 85%
reported that they live in Nakivale, and the median num-
ber of years living in Nakivale for this group was 4 (IQR:
1–8). The majority of enrollees were married or living
with someone (65%) and had some primary school or no
formal schooling (64%). Approximately three-quarters
(73%) reported prior HIV testing. One third of clients
traveled more than one hour to Nakivale clinic.
A total of 330 subjects (4%) were found to be HIV-
infected, of whom 63% were female, the median age was
30 (IQR: 24–38), and 34% were refugees. The HIV-
infected cohort had a higher proportion of participants
who were female, national (i.e. Ugandan non-refugees),
divorced/separated/widowed, and who traveled more
than 1 h to the Nakivale clinic; it had a lower proportion
of subjects who were refugees, residents of Nakivale, sin-
gle, and previously tested for HIV (Table 1). Country of
origin was significantly different between HIV-infected
and non-HIV-infected subjects (p < 0.0001). Most of this
association was driven by the higher proportion of HIV-
infected Ugandans. This was verified by excluding
Ugandans from the analysis of country of origin by HIV
test result using a Pearson chi-square test (p = 0.09).
Ugandans who reported living in the settlement were
less likely to be HIV-infected compared to Ugandans
living outside the settlement (7 vs. 11%, p = 0.009). Of
the three predominant countries of origin represented
by the refugees that participated in HIV testing, the HIV
prevalence among Rwandans was 2.3% (56/2395; 95%
CI: 1.7–3.1%), among Congolese was 1.9% (30/1580; 95%
CI: 1.2–2.7%), and among Burundians was 1.4% (14/987;
95% CI: 0.7–2.4%). The 12 remaining HIV-infected refu-
gees were too few to adequately assess HIV prevalence
by country group.
According to the final multivariable model, refugees
were approximately one quarter as likely as Ugandan
nationals to be HIV-infected (aRR 0.27, CI 0.21–0.34).
Additionally, being female (aRR 1.43, CI 1.14–1.80),
divorced/separated/widowed (aRR 2.41, CI 1.88–3.08),
and traveling more than 1 h to the clinic (aRR 1.39, CI
1.11–1.74) increased the likelihood of being HIV-
infected, while being single (aRR 0.60, CI 0.41–0.86) and
having been tested previously for HIV (aRR 0.59, CI
0.47–0.74) lowered the likelihood of being HIV-infected
(all p-values < 0.05, Table 2). Age, education, and HIV
knowledge did not meet the univariate screening criteria
of p < 0.10.
Discussion
This study of routine HIV screening at Nakivale Health
Center identified participant characteristics that were
associated with likelihood of HIV infection. Clients had
an increased likelihood of being HIV-infected if they
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were female, divorced/separated/widowed, or traveled
more than one hour to clinic. Conversely, clients had a
decreased likelihood of being HIV-infected if they were
a refugee, single, or if they had previously tested for
HIV. Refugees were one quarter as likely to be HIV-
infected compared to Ugandan nationals.
Refugee settlements often have lower HIV prevalence
than surrounding host communities [14]. This finding is
reflected in our data – refugees have a much lower
prevalence than Ugandan nationals (2 vs. 9% respect-
ively). This may be a sign of the lower HIV prevalence
in the refugees’ countries of origin compared to Uganda.
It could be that refugees in Nakivale have fewer sexual
partners overall and fewer casual sexual partners than
Ugandan nationals, as was the case in a series of cross-
sectional HIV behavioral surveillance surveys in Kenya
and Uganda [15]. Ugandans who access HIV screening
services in the refugee settlement may also be a particu-
larly vulnerable subset of the national population. While
conflict and forced displacement have not been shown
to increase HIV prevalence [14, 16, 17], we observed
that some sub-groups of refugees have increased preva-
lence compared to the HIV prevalence in their country
of origin. Comparing the predominant sub-groups of
refugees that tested for HIV in Nakivale to adult
populations (ages 15–49) in their country of origin, we
observed that Congolese refugees had a higher preva-
lence than adults in the Democratic Republic of the
Table 1 Baseline characteristics of cohort
Variable Overall (N = 7766)
% (n/N)
HIV-infected
(N = 330) % (n/N)
Non-HIV-infected
(N = 7436) % (n/N)
P-value*
Female 52% (4016/7766) 63% (208/330) 51% (3808/7436) <0.0001
Age category 0.10
< 30 53% (4132/7766) 49% (160/330) 53% (3972/7436)
30 to <40 26% (2020/7766) 29% (96/330) 26% (1924/7436)
40 to <50 13% (1029/7766) 16% (54/330) 13% (975/7436)
≥ 50 8% (585/7766) 6% (20/330) 8% (565/7436)
Refugee 69% (5318/7743) 34% (113/329) 70% (5205/7414) <0.0001
Live in Nakivale 85% (6430/7534) 63% (205/323) 86% (6225/7211) <0.0001
Country of origin <0.0001
Uganda 32% (2457/7763) 66% (218/330) 30% (2239/7433)
Rwanda 31% (2395/7763) 17% (56/330) 31% (2339/7433)
DRC 20% (1580/7763) 9% (30/330) 21% (1550/7433)
Burundi 13% (987/7763) 4% (14/330) 13% (973/7433)
Other† 4% (344/7763) 4% (12/330) 5% (332/7433)
Relationship status <0.0001
Married/living together 65% (4872/7534) 64% (207/323) 65% (4665/7211)
Single 24% (1832/7534) 11% (37/323) 25% (1795/7211)
Divorced/separated/widowed 11% (830/7534) 25% (79/323) 10% (751/7211)
Education 0.19
No school 20% (1524/7534) 20% (64/323) 20% (1460/7211)
Some primary school 44% (3267/7534) 48% (156/323) 43% (3111/7211)
Completed primary school 16% (1224/7534) 16% (51/323) 16% (1173/7211)
Higher than primary school‡ 20% (1519/7534) 16% (52/323) 21% (1467/7211)
HIV knowledge (all correct)§ 34% (2544/7542) 38% (122/323) 34% (2422/7219) 0.12
Previous HIV test 73% (5538/7536) 65% (210/322) 74% (5328/7214) 0.0006
More than 1 h to clinic 33% (2497/7548) 53% (171/323) 32% (2326/7225) <0.0001
Note: Denominators vary due to participant non-response
Abbreviations: DRC Democratic Republic of the Congo
* P-value based on Pearson chi-square test
† Other includes Somalia, Eritrea, Ethiopia, Sudan, Kenya, Tanzania, Senegal, and Zaire
‡ Includes some/completed secondary school, vocational school, certificate program, bachelors, and post graduate
§ Questionnaire included 4 questions [correct answer]: (1) Do you think that a healthy-looking person can be infected with HIV, the virus that causes AIDS? [Yes];
(2) Can a person get HIV by sharing a meal with someone who is infected? [No]; (3) Can a pregnant woman infected with HIV or AIDS transmit the virus to her
unborn child? [Yes]; (4) Can a woman with HIV or AIDS transmit the virus to her newborn child through breastfeeding? [Yes]
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Congo (1.9 vs. 0.8%) and Burundian refugees had a
higher prevalence than adults in Burundi (1.4 vs. 1.0%)
[11]. Conversely, Rwandans refugees had a lower preva-
lence than adults in Rwanda (2.3 vs. 2.9%) [11]. While
both the Burundian and Rwandan differences are consist-
ent with the rates observed in our study (differences not
statistically significant; both p > 0.05), the differences in
prevalence for refugees from the Democratic Republic of
the Congo should be further evaluated to better under-
stand the characteristics and potential differences of the
people accessing HIV testing. It is evident that HIV infec-
tion is endemic among both refugees and Ugandan na-
tionals and that both groups would benefit from scaled-up
HIV screening and clinical services in Nakivale.
Perhaps most notable in our data is the high prevalence
of HIV among Ugandan nationals compared to refugees.
Though Ugandan nationals do not have land ownership
rights permitting them to live within Nakivale, many do
(Table 1, 5318 report they are refugees, yet 6430 report
they live in Nakivale) and others freely come and go from
the settlement for job-related or personal reasons [18].
Our data reflect that HIV-infected Ugandans are more
likely to report that they live outside of Nakivale Refugee
Settlement. There is concern that some Ugandans may
travel to Nakivale for commercial sex. If Ugandans with
higher prevalence of HIV participate in commercial sex
within Nakivale, this puts those living in the settlement at
higher risk for HIV transmission. Integrated HIV pro-
grams could be an efficient and effective means to reach
both of these groups in this setting [18].
We found a significantly higher likelihood of HIV
among females participating in HIV screening compared
to males. This is similar to findings reported in the 2011
Uganda AIDS Indicator Survey that showed HIV preva-
lence in Uganda to be higher among women than men
(8.3 vs. 6.1% respectively) [13]. It is the case that young
women are disproportionately affected by HIV in sub-
Saharan Africa with women acquiring HIV 5 to 7 years
earlier than men [19]. This could be more pronounced
in refugee settlements as many women were displaced
by armed conflict, and gender-based violence is known
to be used as a weapon of war in this region [20]. A
cross-sectional survey conducted in Northern Uganda in
2010 among transit camp residents showed higher likeli-
hood of HIV infection for those with a non-consensual
sexual debut [21]. Additionally, plural marriages in the
refugee settlement could differentially impact the HIV
prevalence of women.
Those who traveled more than 1 h to reach the clinic
had a higher likelihood of HIV infection. Perhaps those
who traveled further reflect a higher risk or sicker popula-
tion who delayed testing until they were ill [22]. It has
been demonstrated in sub-Saharan Africa that distance to
clinic is a barrier to HIV service utilization [23, 24].
Assuming time to clinic is a proxy for distance to clinic, it
may be that those living farther from clinic have received
less HIV preventative counseling and less treatment for
ailments such as sexually transmitted infections and there-
fore have a higher risk of being infected.
These data must be interpreted within the context of
the study design. The study was conducted in one refugee
settlement. Though there are likely to be similarities in
other refugee settlements, particularly those in Uganda, it
is probable that differences exist between correlates of
HIV infection among populations with different demo-
graphics and countries of origin. Information about study
participants was collected using survey methods, and as
such the data were not verifiable. There was a potential
sampling bias of those living closer to clinic or those
willing and able to travel to clinic to access HIV screening
services. Another sampling bias may be that those acces-
sing testing could be more likely to be sick with an HIV-
related illness as they were physically present at the health
center; this would lead to an overestimate of HIV preva-
lence. This potential bias is particularly important when
we compare HIV prevalence of sub-groups by country;
the differences demonstrated in this study could be
explained by this bias. Though free HIV screening was
Table 2 Predictors of HIV infection
Variable Unadjusted Adjusted
Relative Risk [95% CI] P-value Relative Risk [95% CI] P-value
Refugee 0.24 [0.19, 0.30] <0.0001 0.27 [0.21, 0.34] <0.0001
Female 1.59 [1.27, 1.99] <0.0001 1.43 [1.14, 1.80] 0.002
Relationship status <0.0001 <0.0001
Married/living together REF REF
Single 0.48 [0.33, 0.68] 0.60 [0.41, 0.86]
Divorced/separated/widowed 2.24 [1.74, 2.88] 2.41 [1.88, 3.08]
Previous HIV test 0.68 [0.54, 0.85] 0.0006 0.59 [0.47, 0.74] <0.0001
More than 1 h to clinic 2.28 [1.83, 2.82] <0.0001 1.39 [1.11, 1.74] 0.003
Note: Results are based on binomial regression
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offered to all clients waiting for an outpatient department
clinic visit, less than a quarter of clients presenting for an
outpatient department clinic visit opted to screen for HIV.
Reasons for declining to participate in HIV testing may
have included fear of finding out their HIV status, fear of
stigma, or having a recent HIV test and/or known HIV
status. It may have been that Ugandan nationals who
opted to test for HIV in Nakivale were at higher or lower
risk of HIV infection than Ugandans testing elsewhere.
Despite these limitations, these data are informative and
could help to guide HIV screening and outreach services
for this setting.
Conclusion
This is the first study to assess correlates of HIV infection
among clients accessing HIV screening in a refugee settle-
ment. By understanding more about high-risk populations
accessing HIV screening in Nakivale Refugee Settlement,
we can better target future HIV screening interventions
for this setting. Despite lower prevalence among refugees
compared to Ugandan nationals, both groups have a high
HIV prevalence, supporting the need for enhanced HIV
screening services in Nakivale. Using an evidence-based
approach to enhance HIV screening and treatment inter-
ventions among refugees will help ensure effective and
efficient use of resources for this vulnerable population.
While refugee settlements differ from location to location,
lessons learned in this study may be relevant for other
refugee settlements in Sub-Saharan Africa hosting popula-
tions with similar demographics including the 9 other
refugee settlements in Uganda.
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